Cullin-3/KCTD10 E3 complex is essential for Rac1 activation through RhoB degradation in human epidermal growth factor receptor 2-positive breast cancer cells

Akari Murakami, Masashi Maekawa, Katsuhisa Kawai, Jun Nakayama, Nobukazu Araki, Kentaro Semba, Tomohiko Taguchi, Yoshiaki Kamei, Yasutsugu Takada, Shigeki Higashiyama

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Rho GTPase Rac1 is a central regulator of F-actin organization and signal transduction to control plasma membrane dynamics and cell proliferation. Dysregulated Rac1 activity is often observed in various cancers including breast cancer and is suggested to be critical for malignancy. Here, we showed that the ubiquitin E3 ligase complex Cullin-3 (CUL3)/KCTD10 is essential for epidermal growth factor (EGF)-induced/human epidermal growth factor receptor 2 (HER2)-dependent Rac1 activation in HER2-positive breast cancer cells. EGF-induced dorsal membrane ruffle formation and cell proliferation that depends on both Rac1 and HER2 were suppressed in CUL3- or KCTD10-depleted cells. Mechanistically, CUL3/KCTD10 ubiquitinated RhoB for degradation, another Rho GTPase that inhibits Rac1 activation at the plasma membrane by suppressing endosome-to-plasma membrane traffic of Rac1. In HER2-positive breast cancers, high expression of Rac1 mRNA significantly correlated with poor prognosis of the patients. This study shows that this novel molecular axis (CUL3/KCTD10/RhoB) positively regulates the activity of Rac1 in HER2-positive breast cancers, and our findings may lead to new treatment options for HER2- and Rac1-positive breast cancers.

Original languageEnglish
Pages (from-to)650-661
Number of pages12
JournalCancer Science
Volume110
Issue number2
DOIs
Publication statusPublished - 2019 Feb 1

Fingerprint

Cullin Proteins
Breast Neoplasms
rho GTP-Binding Proteins
Cell Membrane
Epidermal Growth Factor
Cell Proliferation
Ubiquitin-Protein Ligases
Endosomes
Plasma Cells
human ERBB2 protein
Actins
Signal Transduction
Messenger RNA
Membranes

Keywords

  • Cullin-3
  • HER2
  • membrane ruffle
  • Rac1
  • RhoB

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Cullin-3/KCTD10 E3 complex is essential for Rac1 activation through RhoB degradation in human epidermal growth factor receptor 2-positive breast cancer cells. / Murakami, Akari; Maekawa, Masashi; Kawai, Katsuhisa; Nakayama, Jun; Araki, Nobukazu; Semba, Kentaro; Taguchi, Tomohiko; Kamei, Yoshiaki; Takada, Yasutsugu; Higashiyama, Shigeki.

In: Cancer Science, Vol. 110, No. 2, 01.02.2019, p. 650-661.

Research output: Contribution to journalArticle

Murakami, Akari ; Maekawa, Masashi ; Kawai, Katsuhisa ; Nakayama, Jun ; Araki, Nobukazu ; Semba, Kentaro ; Taguchi, Tomohiko ; Kamei, Yoshiaki ; Takada, Yasutsugu ; Higashiyama, Shigeki. / Cullin-3/KCTD10 E3 complex is essential for Rac1 activation through RhoB degradation in human epidermal growth factor receptor 2-positive breast cancer cells. In: Cancer Science. 2019 ; Vol. 110, No. 2. pp. 650-661.
@article{c981c67dfd1449f7b62dc12bde4bb755,
title = "Cullin-3/KCTD10 E3 complex is essential for Rac1 activation through RhoB degradation in human epidermal growth factor receptor 2-positive breast cancer cells",
abstract = "Rho GTPase Rac1 is a central regulator of F-actin organization and signal transduction to control plasma membrane dynamics and cell proliferation. Dysregulated Rac1 activity is often observed in various cancers including breast cancer and is suggested to be critical for malignancy. Here, we showed that the ubiquitin E3 ligase complex Cullin-3 (CUL3)/KCTD10 is essential for epidermal growth factor (EGF)-induced/human epidermal growth factor receptor 2 (HER2)-dependent Rac1 activation in HER2-positive breast cancer cells. EGF-induced dorsal membrane ruffle formation and cell proliferation that depends on both Rac1 and HER2 were suppressed in CUL3- or KCTD10-depleted cells. Mechanistically, CUL3/KCTD10 ubiquitinated RhoB for degradation, another Rho GTPase that inhibits Rac1 activation at the plasma membrane by suppressing endosome-to-plasma membrane traffic of Rac1. In HER2-positive breast cancers, high expression of Rac1 mRNA significantly correlated with poor prognosis of the patients. This study shows that this novel molecular axis (CUL3/KCTD10/RhoB) positively regulates the activity of Rac1 in HER2-positive breast cancers, and our findings may lead to new treatment options for HER2- and Rac1-positive breast cancers.",
keywords = "Cullin-3, HER2, membrane ruffle, Rac1, RhoB",
author = "Akari Murakami and Masashi Maekawa and Katsuhisa Kawai and Jun Nakayama and Nobukazu Araki and Kentaro Semba and Tomohiko Taguchi and Yoshiaki Kamei and Yasutsugu Takada and Shigeki Higashiyama",
year = "2019",
month = "2",
day = "1",
doi = "10.1111/cas.13899",
language = "English",
volume = "110",
pages = "650--661",
journal = "Cancer Science",
issn = "1347-9032",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Cullin-3/KCTD10 E3 complex is essential for Rac1 activation through RhoB degradation in human epidermal growth factor receptor 2-positive breast cancer cells

AU - Murakami, Akari

AU - Maekawa, Masashi

AU - Kawai, Katsuhisa

AU - Nakayama, Jun

AU - Araki, Nobukazu

AU - Semba, Kentaro

AU - Taguchi, Tomohiko

AU - Kamei, Yoshiaki

AU - Takada, Yasutsugu

AU - Higashiyama, Shigeki

PY - 2019/2/1

Y1 - 2019/2/1

N2 - Rho GTPase Rac1 is a central regulator of F-actin organization and signal transduction to control plasma membrane dynamics and cell proliferation. Dysregulated Rac1 activity is often observed in various cancers including breast cancer and is suggested to be critical for malignancy. Here, we showed that the ubiquitin E3 ligase complex Cullin-3 (CUL3)/KCTD10 is essential for epidermal growth factor (EGF)-induced/human epidermal growth factor receptor 2 (HER2)-dependent Rac1 activation in HER2-positive breast cancer cells. EGF-induced dorsal membrane ruffle formation and cell proliferation that depends on both Rac1 and HER2 were suppressed in CUL3- or KCTD10-depleted cells. Mechanistically, CUL3/KCTD10 ubiquitinated RhoB for degradation, another Rho GTPase that inhibits Rac1 activation at the plasma membrane by suppressing endosome-to-plasma membrane traffic of Rac1. In HER2-positive breast cancers, high expression of Rac1 mRNA significantly correlated with poor prognosis of the patients. This study shows that this novel molecular axis (CUL3/KCTD10/RhoB) positively regulates the activity of Rac1 in HER2-positive breast cancers, and our findings may lead to new treatment options for HER2- and Rac1-positive breast cancers.

AB - Rho GTPase Rac1 is a central regulator of F-actin organization and signal transduction to control plasma membrane dynamics and cell proliferation. Dysregulated Rac1 activity is often observed in various cancers including breast cancer and is suggested to be critical for malignancy. Here, we showed that the ubiquitin E3 ligase complex Cullin-3 (CUL3)/KCTD10 is essential for epidermal growth factor (EGF)-induced/human epidermal growth factor receptor 2 (HER2)-dependent Rac1 activation in HER2-positive breast cancer cells. EGF-induced dorsal membrane ruffle formation and cell proliferation that depends on both Rac1 and HER2 were suppressed in CUL3- or KCTD10-depleted cells. Mechanistically, CUL3/KCTD10 ubiquitinated RhoB for degradation, another Rho GTPase that inhibits Rac1 activation at the plasma membrane by suppressing endosome-to-plasma membrane traffic of Rac1. In HER2-positive breast cancers, high expression of Rac1 mRNA significantly correlated with poor prognosis of the patients. This study shows that this novel molecular axis (CUL3/KCTD10/RhoB) positively regulates the activity of Rac1 in HER2-positive breast cancers, and our findings may lead to new treatment options for HER2- and Rac1-positive breast cancers.

KW - Cullin-3

KW - HER2

KW - membrane ruffle

KW - Rac1

KW - RhoB

UR - http://www.scopus.com/inward/record.url?scp=85061061763&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061061763&partnerID=8YFLogxK

U2 - 10.1111/cas.13899

DO - 10.1111/cas.13899

M3 - Article

C2 - 30515933

AN - SCOPUS:85061061763

VL - 110

SP - 650

EP - 661

JO - Cancer Science

JF - Cancer Science

SN - 1347-9032

IS - 2

ER -